Aqueous based polymeric dispersion: Plackett-Burman design for screening of formulation variables of atenolol gastrointestinal therapeutic system

Pharmaceutica Acta Helvetiae

Volumn 73, Issue 2, 1998, Pages 105-112

  Sastry, S V ^a   Khan, M A ^a  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

Author keywords

CA pseudolatex; Formulation variables; GITS; Plackett Burman design

Indexed keywords

ATENOLOL; CARBOMER; OSMOTIC AGENT; SODIUM CHLORIDE;

ARTICLE; COMPRESSION; DISSOLUTION; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG MANUFACTURE; DRUG RELEASE; EMULSION; IN VITRO STUDY; PRESSURE; TECHNIQUE; TEMPERATURE;

ADRENERGIC BETA-ANTAGONISTS; ATENOLOL; CELLULOSE; DELAYED-ACTION PREPARATIONS; EXCIPIENTS; MEMBRANES, ARTIFICIAL; OSMOSIS;

EID: 0031817516     PISSN: 00316865     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-6865(97)00052-6     Document Type: Article

References (20)

1. Banakar U.V. Drug delivery systems of 90's: innovations in controlled release. Am. Pharm. N. 527:1987;39-48.
2. Bichard S.R. Evaluation of cellulose acetate (CA) latex as coating material for controlled release products. Proc. Int. Symp. Contr. Rel. Bioact. Mater. 17:1990;321-322.
3. Binschaedler C., Gurny R., Doelker E. Mechanically strong films produced from cellulose acetate latexes. J. Pharm. Pharmacol. 39:1987;335-338.
4. Binschaedler C., Gurny R., Doelker E. Osmotic water transport through cellulose acetate membranes produced from a latex system. J. Pharm. Sci. 76:1987;455-460.
5. Binschaedler C., Gurny R., Doelker E. Osmotically controlled drug delivery systems produced from organic solutions and aqueous dispersions of cellulose acetate. J. Contr. Rel. 4:1986;203-212.
6. Bolton, S., 1990. Pharmaceutical Statistics: Practical and Clinical Applications, Chap. 9. Marcel Dekker, New York, pp. 308-337.
7. Carbopol® product bulletin, 1994. B.F. Goodrich, Cleveland, OH.
8. Chao S.T., Pinson D., Coen P., Pruitt B., Knowles M., Place V. Effect of food on bioavailability of pseudoephedrine and bromphenaramine administered from a gastrointestinal therapeutic system. J. Pharm. Sci. 80:1991;432-435.
9. Janicki S., Jedras Z., Sawicki W. Oral therapeutic system delivering a water insoluble drug: N-{4-[2-(3-methylpyrazole-1-corbonamide) ethyl]-benzenesulfonyl}N-cyclohexylurea (SPC-5002). Act. Pharm. Huga. 58:1988;145-151.
10. Jedras Z. One compartment gastrointestinal therapeutic system for chlorpromazine hydrochloride. Act. Pharm. Jugosl. 37:1987;149-154.
11. Jonkman J.H.G. Food interactions with sustained release theophylline preparations. A review. Clin. Pharmacokinet. 16:1989;162-179.
12. Karnachi A.A., Reddy I.K., DeGennaro M.D., Khan M.A. Comparative evaluation of the severity of gastric ulceration by solid dispersions and coprecipitates of Indomethacin. J. Drug. Targ. 4:1997;297-301.
13. Khan M.A., Karnachi A.A., Singh S.K., Sastry S.V., Kislalioglu S.M., Bolton S. Controlled release coprecipitates: formulation considerations. J. Contr. Rel. 37:1995;132-141.
14. Murray, J.S., Jr., 1984. Screening Experiments. X-Stat Manual, Ver 1.1. Wiley, New York, pp. 210-251.
15. Sastry, S.V., Khan, M.A., 1997. Aqueous-Based Polymeric Dispersion: Face-centered Cubic Design for the Development of Atenolol Gastrointestinal Therapeutic System. Pharm. Dev. Tech., accepted for publication.
16. Sastry S.V., Reddy I.K., Khan M.A. Atenolol gastrointestinal therapeutic system: optimization of formulation variables using response surface methodology. J. Contr. Rel. 45:1997;121-130.
17. Sastry S.V., DeGennaro M.D., Reddy I.K., Khan M.A. Atenolol gastrointestinal therapeutic system: I. Screening of formulation variables. Drug. Dev. Ind. Pharm. 23:1997;157-165.
18. Swanson D.R., Barclay B.L., Wong P.S.L., Theeuwes F. Nefidipine gastrointestinal therapeutic system. Am. J. Med. 83(3):1987;3-9. suppl. 6B.
19. Theeuwes F. Elementary osmotic pump. J. Pharm. Sci. 64:1975;1987-1991.
20. Zentner G.M., Rork G.S., Himmelstein K.J. Osmotic flow through controlled porosity films: an approach to delivery of water soluble compounds. J. Contr. Rel. 2:1985;217-229.